VIRCO BVBA
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 23, 2016 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 248 Total Citation Count
- Jul 24, 1998 Earliest Filing
- 20 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8945833 Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of hepatitis C virus (HCV) for genotypes 1 to 6Oct 06, 09Feb 03, 15[C12Q]
8563236 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistanceJan 13, 09Oct 22, 13[C12Q, C12P]
7977053 Circular probe amplification (CPA) using energy-transfer primersDec 12, 06Jul 12, 11[C07H, C12Q, C12P]
7494768 Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistanceMay 30, 00Feb 24, 09[C12Q, C12P]
7058616 Method and system for predicting resistance of a disease to a therapeutic agent using a neural networkJun 08, 00Jun 06, 06[G06N]
6221578 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsJul 24, 98Apr 24, 01[C07H, C12Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0177,407 METHOD FOR DETERMINING DRUG RESISTANCE MUTATIONS IN ANY OF THE NON-STRUCTURAL PROTEIN REGIONS NS3 TO NS5B OF HEPATITIS C VIRUS (HCV) FOR GENOTYPES 1 TO 6AbandonedDec 22, 14Jun 23, 16[C12Q, C07K]
2014/0025,310 METHOD FOR DETERMINING THE EFFICACY OF A COMBINATION THERAPYAbandonedSep 18, 13Jan 23, 14[G06F]
8574831 Mutational profiles in HIV-1 reverse transcriptase correlated with phenotypic drug resistanceExpiredNov 01, 07Nov 05, 13[C12Q]
2013/0079,506 METHOD FOR DESIGNING A DRUG REGIME FOR HIV-INFECTED PATIENTSAbandonedNov 05, 12Mar 28, 13[C07H]
2011/0146,387 Measurement system and method for determination and/or detection of one or more agents in one or more samples using said measurement systemAbandonedDec 16, 10Jun 23, 11[G01N]
2011/0020,831 GENETIC DETECTION OF HIV-1 STRAINS THAT USE THE CXCR4 CO-RECEPTORAbandonedMar 20, 09Jan 27, 11[C12Q]
7292944 Establishment of biological cut-off values for predicting resistance to therapyExpiredOct 22, 01Nov 06, 07[G06F]
2005/0064,397 Method for mutation detection in HIV-1 using pol sequencingAbandonedSep 08, 04Mar 24, 05[C12Q, C12P]
2004/0073,378 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistanceAbandonedApr 16, 03Apr 15, 04[G01N, G06F]
2004/0067,511 Circular probe amplification (cpa) using energy-transfer primersAbandonedAug 22, 03Apr 08, 04[C12Q, C12P]
2003/0190,603 Method and system for predicting therapeutic agent resistance and for defining the genetic basis of drug resistance using neural networksAbandonedJun 02, 03Oct 09, 03[C12Q, G01N, G06F]
2003/0152,917 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsAbandonedJan 15, 03Aug 14, 03[C12Q, C12N, G01N, G06F]
6528251 Method of managing the chemotherapy of patients who are HIV positive based on the phenotypic drug sensitivity of human HIV strainsExpiredDec 14, 00Mar 04, 03[C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.